Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SKGR
1926
DELISTED
SK Growth Opportunities Corporation Class A Common Stock
SKGR
| $10.6M | 0.01% |
1,000,000
| – | – |
|
1927
Lifestance Health
LFST
$4.72B
| $10.6M | 0.01% |
1,159,780
-845,421
| -42% | -$7.02M |
|
1928
X4 Pharmaceuticals
XFOR
$407M
| $10.6M | 0.01% |
181,720
+145,713
| +405% | +$7.49M |
|
1929
CALL
Johnson Controls International
JCI
$87.7B
| $10.6M | 0.01% |
155,000
+30,700
| +25% | +$1.89M |
|
|
DAY
1930
DELISTED
Dayforce
DAY
| $10.5M | 0.01% |
157,423
-625,559
| -80% | -$40.3M |
|
1931
PUT
iShares MSCI Canada ETF
EWC
$6.92B
| $10.5M | 0.01% |
300,000
| – | – |
|
1932
Eagle Bancorp
EGBN
$841M
| $10.5M | 0.01% |
494,264
+93,116
| +23% | +$2.19M |
|
1933
Certara
CERT
$1.24B
| $10.5M | 0.01% |
574,329
+519,360
| +945% | +$11M |
|
|
AMWD
1934
DELISTED
American Woodmark
AMWD
| $10.5M | 0.01% |
136,864
-75,740
| -36% | -$4.4M |
|
1935
Factset
FDS
$10.4B
| $10.4M | 0.01% |
26,027
-89,727
| -78% | -$36.2M |
|
1936
Immunovant
IMVT
$8.98B
| $10.4M | 0.01% |
549,146
-533,756
| -49% | -$9.95M |
|
1937
First Bancorp
FBP
$4.31B
| $10.4M | 0.01% |
852,184
+247,215
| +41% | +$2.88M |
|
1938
PUT
Aptiv
APTV
$9.62B
| $10.4M | 0.01% |
102,000
+80,600
| +377% | +$7.97M |
|
1939
PUT
Zscaler
ZS
$27.2B
| $10.4M | 0.01% |
71,100
+26,400
| +59% | +$3.22M |
|
1940
PUT
iQIYI
IQ
$965M
| $10.4M | 0.01% |
1,947,000
+837,000
| +75% | +$4.71M |
|
1941
Bausch Health
BHC
$2.47B
| $10.4M | 0.01% |
1,298,575
+36,472
| +3% | +$269K |
|
1942
Cavco Industries
CVCO
$4.43B
| $10.4M | 0.01% |
35,210
+26,197
| +291% | +$7.53M |
|
1943
CALL
Marathon Petroleum
MPC
$101B
| $10.4M | 0.01% |
88,900
-182,600
| -67% | -$21.2M |
|
1944
CALL
Intuitive Surgical
ISRG
$130B
| $10.4M | 0.01% |
30,300
-225,600
| -88% | -$68.3M |
|
|
PEGR
1945
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $10.4M | 0.01% |
1,000,000
| – | – |
|
1946
CALL
DraftKings
DKNG
$12.4B
| $10.4M | 0.01% |
389,700
+49,800
| +15% | +$1.15M |
|
1947
CALL
Antero Resources
AR
$11.9B
| $10.3M | 0.01% |
448,900
-8,000
| -2% | -$178K |
|
1948
Kadant
KAI
$3.61B
| $10.3M | 0.01% |
46,419
+45,276
| +3,961% | +$9.07M |
|
1949
Concentrix
CNXC
$1.63B
| $10.3M | 0.01% |
127,654
+8,834
| +7% | +$826K |
|
|
JKS
1950
PUT
JinkoSolar
JKS
$702M
| $10.3M | 0.01% |
232,100
+227,000
| +4,451% | +$10.3M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.